{"id":497,"date":"2026-10-19T19:37:37","date_gmt":"2026-10-19T19:37:37","guid":{"rendered":"https:\/\/healthpana.com\/?p=497"},"modified":"2026-10-19T19:37:40","modified_gmt":"2026-10-19T19:37:40","slug":"european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal","status":"publish","type":"post","link":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/","title":{"rendered":"European\u00a0Commission\u00a0Accuses\u00a0KKR\u00a0of\u00a0Providing\u00a0Misleading\u00a0Information\u00a0in\u00a0Telecom\u00a0Deal"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong><span style=\"font-family: -webkit-standard; white-space: normal;\">BRUSSELS<\/span>\u00a0| October 19, 2026<\/strong>\u00a0<strong>| Health Pana<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The&nbsp;European&nbsp;Commission&nbsp;has&nbsp;formally&nbsp;accused&nbsp;US&nbsp;private&nbsp;equity&nbsp;firm&nbsp;KKR&nbsp;of&nbsp;providing&nbsp;misleading&nbsp;information&nbsp;during&nbsp;its&nbsp;review&nbsp;of&nbsp;the&nbsp;company&#8217;s&nbsp;\u20ac22&nbsp;billion&nbsp;acquisition&nbsp;of&nbsp;Telecom&nbsp;Italia&#8217;s&nbsp;fixed-line&nbsp;network.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The&nbsp;Commission&#8217;s&nbsp;action&nbsp;concerns&nbsp;information&nbsp;provided&nbsp;during&nbsp;the&nbsp;regulatory&nbsp;review&nbsp;of&nbsp;the&nbsp;transaction&nbsp;in&nbsp;2024.&nbsp;The&nbsp;investigation&nbsp;followed&nbsp;complaints&nbsp;from&nbsp;rival&nbsp;telecommunications&nbsp;operators&nbsp;about&nbsp;access&nbsp;conditions&nbsp;and&nbsp;pricing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The&nbsp;Commission&nbsp;has&nbsp;issued&nbsp;a&nbsp;formal&nbsp;statement&nbsp;of&nbsp;objections,&nbsp;giving&nbsp;KKR&nbsp;an&nbsp;opportunity&nbsp;to&nbsp;respond&nbsp;to&nbsp;the&nbsp;allegations.&nbsp;If&nbsp;the&nbsp;alleged&nbsp;infringement&nbsp;is&nbsp;established,&nbsp;the&nbsp;company&nbsp;could&nbsp;face&nbsp;a&nbsp;fine&nbsp;of&nbsp;up&nbsp;to&nbsp;1%&nbsp;of&nbsp;its&nbsp;global&nbsp;revenue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">KKR&nbsp;has&nbsp;denied&nbsp;misrepresenting&nbsp;information&nbsp;and&nbsp;said&nbsp;it&nbsp;intends&nbsp;to&nbsp;challenge&nbsp;the&nbsp;allegations&nbsp;while&nbsp;cooperating&nbsp;with&nbsp;the&nbsp;regulator.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The&nbsp;case&nbsp;highlights&nbsp;the&nbsp;importance&nbsp;of&nbsp;accurate&nbsp;disclosures&nbsp;during&nbsp;merger&nbsp;reviews&nbsp;and&nbsp;the&nbsp;role&nbsp;of&nbsp;regulatory&nbsp;oversight&nbsp;in&nbsp;protecting&nbsp;competition&nbsp;and&nbsp;market&nbsp;integrity.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source:&nbsp;Reuters.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BRUSSELS\u00a0| October 19, 2026\u00a0| Health Pana The&nbsp;European&nbsp;Commission&nbsp;has&nbsp;formally&nbsp;accused&nbsp;US&nbsp;private&nbsp;equity&nbsp;firm&nbsp;KKR&nbsp;of&nbsp;providing&nbsp;misleading&nbsp;information&nbsp;during&nbsp;its&nbsp;review&nbsp;of&nbsp;the&nbsp;company&#8217;s&nbsp;\u20ac22&nbsp;billion&nbsp;acquisition&nbsp;of&nbsp;Telecom&nbsp;Italia&#8217;s&nbsp;fixed-line&nbsp;network. The&nbsp;Commission&#8217;s&nbsp;action&nbsp;concerns&nbsp;information&nbsp;provided&nbsp;during&nbsp;the&nbsp;regulatory&nbsp;review&nbsp;of&nbsp;the&nbsp;transaction&nbsp;in&nbsp;2024.&nbsp;The&nbsp;investigation&nbsp;followed&nbsp;complaints&nbsp;from&nbsp;rival&nbsp;telecommunications&nbsp;operators&nbsp;about&nbsp;access&nbsp;conditions&nbsp;and&nbsp;pricing. The&nbsp;Commission&nbsp;has&nbsp;issued&nbsp;a&nbsp;formal&nbsp;statement&nbsp;of&nbsp;objections,&nbsp;giving&nbsp;KKR&nbsp;an&nbsp;opportunity&nbsp;to&nbsp;respond&nbsp;to&nbsp;the&nbsp;allegations.&nbsp;If&nbsp;the&nbsp;alleged&nbsp;infringement&nbsp;is&nbsp;established,&nbsp;the&nbsp;company&nbsp;could&nbsp;face&nbsp;a&nbsp;fine&nbsp;of&nbsp;up&nbsp;to&nbsp;1%&nbsp;of&nbsp;its&nbsp;global&nbsp;revenue. KKR&nbsp;has&nbsp;denied&nbsp;misrepresenting&nbsp;information&nbsp;and&nbsp;said&nbsp;it&nbsp;intends&nbsp;to&nbsp;challenge&nbsp;the&nbsp;allegations&nbsp;while&nbsp;cooperating&nbsp;with&nbsp;the&nbsp;regulator. The&nbsp;case&nbsp;highlights&nbsp;the&nbsp;importance&nbsp;of&nbsp;accurate&nbsp;disclosures&nbsp;during&nbsp;merger&nbsp;reviews&nbsp;and&nbsp;the&nbsp;role&nbsp;of&nbsp;regulatory&nbsp;oversight&nbsp;in&nbsp;protecting&nbsp;competition&nbsp;and&nbsp;market&nbsp;integrity. Source:&nbsp;Reuters.<\/p>\n","protected":false},"author":2,"featured_media":501,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_templately_pack_id":"","_templately_imported_at":"","_templately_source":"","_templately_import_session_id":"","footnotes":""},"categories":[12,21],"tags":[],"class_list":["post-497","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corruption","category-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company&#039;s \u20ac22 billion acquisition of Telecom Italia&#039;s fixed-line network. The Commission&#039;s action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Health Pana\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"-\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -\" \/>\n\t\t<meta property=\"og:description\" content=\"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company&#039;s \u20ac22 billion acquisition of Telecom Italia&#039;s fixed-line network. The Commission&#039;s action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-19T19:37:37+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-19T19:37:40+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -\" \/>\n\t\t<meta name=\"twitter:description\" content=\"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company&#039;s \u20ac22 billion acquisition of Telecom Italia&#039;s fixed-line network. The Commission&#039;s action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#blogposting\",\"name\":\"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -\",\"headline\":\"European\\u00a0Commission\\u00a0Accuses\\u00a0KKR\\u00a0of\\u00a0Providing\\u00a0Misleading\\u00a0Information\\u00a0in\\u00a0Telecom\\u00a0Deal\",\"author\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/healthpana.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/1l8ug6715ghRv9rfEj_HX3Td1X1O0eO4W1gqoDssScSVFLYHqxhFNkgh8QJQEbbHCrLjndR1qBAcJLjGatddUXknS2Iq8NTvgp4ZwJWNp53R8G0msLsLHCcRb56XGJaK3jJLpiCtnLDWDfdvn9Xhg5QNtGxr3qBlZEPYZxKMLiI.jpeg\",\"width\":1539,\"height\":860},\"datePublished\":\"2026-10-19T19:37:37+00:00\",\"dateModified\":\"2026-10-19T19:37:40+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#webpage\"},\"articleSection\":\"Corruption, NEWS\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/healthpana.com\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/category\\\/corruption\\\/#listItem\",\"name\":\"Corruption\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/category\\\/corruption\\\/#listItem\",\"position\":2,\"name\":\"Corruption\",\"item\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/category\\\/corruption\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#listItem\",\"name\":\"European\\u00a0Commission\\u00a0Accuses\\u00a0KKR\\u00a0of\\u00a0Providing\\u00a0Misleading\\u00a0Information\\u00a0in\\u00a0Telecom\\u00a0Deal\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#listItem\",\"position\":3,\"name\":\"European\\u00a0Commission\\u00a0Accuses\\u00a0KKR\\u00a0of\\u00a0Providing\\u00a0Misleading\\u00a0Information\\u00a0in\\u00a0Telecom\\u00a0Deal\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/category\\\/corruption\\\/#listItem\",\"name\":\"Corruption\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/#organization\",\"url\":\"https:\\\/\\\/healthpana.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/healthpana.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#organizationLogo\",\"width\":1480,\"height\":434},\"image\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/author\\\/admin\\\/\",\"name\":\"Health Pana\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fbc2f81b03f021a16da07d6b25cd2e97995944f9c0074f33b4ead51293076769?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Health Pana\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#webpage\",\"url\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/\",\"name\":\"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -\",\"description\":\"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company's \\u20ac22 billion acquisition of Telecom Italia's fixed-line network. The Commission's action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/healthpana.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/1l8ug6715ghRv9rfEj_HX3Td1X1O0eO4W1gqoDssScSVFLYHqxhFNkgh8QJQEbbHCrLjndR1qBAcJLjGatddUXknS2Iq8NTvgp4ZwJWNp53R8G0msLsLHCcRb56XGJaK3jJLpiCtnLDWDfdvn9Xhg5QNtGxr3qBlZEPYZxKMLiI.jpeg\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#mainImage\",\"width\":1539,\"height\":860},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/index.php\\\/2026\\\/10\\\/19\\\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\\\/#mainImage\"},\"datePublished\":\"2026-10-19T19:37:37+00:00\",\"dateModified\":\"2026-10-19T19:37:40+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/healthpana.com\\\/#website\",\"url\":\"https:\\\/\\\/healthpana.com\\\/\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/healthpana.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -","description":"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company's \u20ac22 billion acquisition of Telecom Italia's fixed-line network. The Commission's action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.","canonical_url":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#blogposting","name":"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -","headline":"European\u00a0Commission\u00a0Accuses\u00a0KKR\u00a0of\u00a0Providing\u00a0Misleading\u00a0Information\u00a0in\u00a0Telecom\u00a0Deal","author":{"@id":"https:\/\/healthpana.com\/index.php\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/healthpana.com\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/10\/1l8ug6715ghRv9rfEj_HX3Td1X1O0eO4W1gqoDssScSVFLYHqxhFNkgh8QJQEbbHCrLjndR1qBAcJLjGatddUXknS2Iq8NTvgp4ZwJWNp53R8G0msLsLHCcRb56XGJaK3jJLpiCtnLDWDfdvn9Xhg5QNtGxr3qBlZEPYZxKMLiI.jpeg","width":1539,"height":860},"datePublished":"2026-10-19T19:37:37+00:00","dateModified":"2026-10-19T19:37:40+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#webpage"},"isPartOf":{"@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#webpage"},"articleSection":"Corruption, NEWS"},{"@type":"BreadcrumbList","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/healthpana.com\/#listItem","position":1,"name":"Home","item":"https:\/\/healthpana.com\/","nextItem":{"@type":"ListItem","@id":"https:\/\/healthpana.com\/index.php\/category\/corruption\/#listItem","name":"Corruption"}},{"@type":"ListItem","@id":"https:\/\/healthpana.com\/index.php\/category\/corruption\/#listItem","position":2,"name":"Corruption","item":"https:\/\/healthpana.com\/index.php\/category\/corruption\/","nextItem":{"@type":"ListItem","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#listItem","name":"European\u00a0Commission\u00a0Accuses\u00a0KKR\u00a0of\u00a0Providing\u00a0Misleading\u00a0Information\u00a0in\u00a0Telecom\u00a0Deal"},"previousItem":{"@type":"ListItem","@id":"https:\/\/healthpana.com\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#listItem","position":3,"name":"European\u00a0Commission\u00a0Accuses\u00a0KKR\u00a0of\u00a0Providing\u00a0Misleading\u00a0Information\u00a0in\u00a0Telecom\u00a0Deal","previousItem":{"@type":"ListItem","@id":"https:\/\/healthpana.com\/index.php\/category\/corruption\/#listItem","name":"Corruption"}}]},{"@type":"Organization","@id":"https:\/\/healthpana.com\/#organization","url":"https:\/\/healthpana.com\/","logo":{"@type":"ImageObject","url":"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#organizationLogo","width":1480,"height":434},"image":{"@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/healthpana.com\/index.php\/author\/admin\/#author","url":"https:\/\/healthpana.com\/index.php\/author\/admin\/","name":"Health Pana","image":{"@type":"ImageObject","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/fbc2f81b03f021a16da07d6b25cd2e97995944f9c0074f33b4ead51293076769?s=96&d=mm&r=g","width":96,"height":96,"caption":"Health Pana"}},{"@type":"WebPage","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#webpage","url":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/","name":"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -","description":"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company's \u20ac22 billion acquisition of Telecom Italia's fixed-line network. The Commission's action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/healthpana.com\/#website"},"breadcrumb":{"@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#breadcrumblist"},"author":{"@id":"https:\/\/healthpana.com\/index.php\/author\/admin\/#author"},"creator":{"@id":"https:\/\/healthpana.com\/index.php\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/10\/1l8ug6715ghRv9rfEj_HX3Td1X1O0eO4W1gqoDssScSVFLYHqxhFNkgh8QJQEbbHCrLjndR1qBAcJLjGatddUXknS2Iq8NTvgp4ZwJWNp53R8G0msLsLHCcRb56XGJaK3jJLpiCtnLDWDfdvn9Xhg5QNtGxr3qBlZEPYZxKMLiI.jpeg","@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#mainImage","width":1539,"height":860},"primaryImageOfPage":{"@id":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/#mainImage"},"datePublished":"2026-10-19T19:37:37+00:00","dateModified":"2026-10-19T19:37:40+00:00"},{"@type":"WebSite","@id":"https:\/\/healthpana.com\/#website","url":"https:\/\/healthpana.com\/","inLanguage":"en-US","publisher":{"@id":"https:\/\/healthpana.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"-","og:type":"article","og:title":"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -","og:description":"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company's \u20ac22 billion acquisition of Telecom Italia's fixed-line network. The Commission's action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.","og:url":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/","og:image":"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png","og:image:secure_url":"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png","article:published_time":"2026-10-19T19:37:37+00:00","article:modified_time":"2026-10-19T19:37:40+00:00","twitter:card":"summary_large_image","twitter:title":"European Commission Accuses KKR of Providing Misleading Information in Telecom Deal -","twitter:description":"BRUSSELS | October 19, 2026 | Health Pana The European Commission has formally accused US private equity firm KKR of providing misleading information during its review of the company's \u20ac22 billion acquisition of Telecom Italia's fixed-line network. The Commission's action concerns information provided during the regulatory review of the transaction in 2024. The investigation followed complaints from rival telecommunications operators about access conditions and pricing. The Commission has issued a formal statement of objections, giving KKR an opportunity to respond to the allegations. If the alleged infringement is established, the company could face a fine of up to 1% of its global revenue. KKR has denied misrepresenting information and said it intends to challenge the allegations while cooperating with the regulator. The case highlights the importance of accurate disclosures during merger reviews and the role of regulatory oversight in protecting competition and market integrity. Source: Reuters.","twitter:image":"https:\/\/healthpana.com\/wp-content\/uploads\/2026\/02\/cropped-Screenshot-2026-02-16-at-2.05.22-AM.png"},"aioseo_meta_data":{"post_id":"497","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-10-19 19:32:10","updated":"2026-10-19 20:16:38","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/healthpana.com\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/healthpana.com\/index.php\/category\/corruption\/\" title=\"Corruption\">Corruption<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tEuropean Commission Accuses KKR of Providing Misleading Information in Telecom Deal\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/healthpana.com\/"},{"label":"Corruption","link":"https:\/\/healthpana.com\/index.php\/category\/corruption\/"},{"label":"European\u00a0Commission\u00a0Accuses\u00a0KKR\u00a0of\u00a0Providing\u00a0Misleading\u00a0Information\u00a0in\u00a0Telecom\u00a0Deal","link":"https:\/\/healthpana.com\/index.php\/2026\/10\/19\/european-commission-accuses-kkr-of-providing-misleading-information-in-telecom-deal\/"}],"_links":{"self":[{"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/posts\/497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/comments?post=497"}],"version-history":[{"count":1,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/posts\/497\/revisions"}],"predecessor-version":[{"id":502,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/posts\/497\/revisions\/502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/media\/501"}],"wp:attachment":[{"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/media?parent=497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/categories?post=497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthpana.com\/index.php\/wp-json\/wp\/v2\/tags?post=497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}